Skip to content

Effect of Rasnadipanchdashakam Kwatha in Amavata ( Rheumatoid Arthritis)

"A CLINICAL STUDY ON RASNADI PANCHDASHAKAM KWATHA IN THE MANAGEMENT OF AMAVATA (RHEUMATOID ARTHRITIS)

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046811
Enrollment
40
Registered
2022-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

None listed

Sponsors

University Post Graduate Institute of Ayurved Studies and Research Jodhpur Rajasthan
Lead Sponsor
Dr Megha Kumawat
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients Aged Between 20 To 50 Years in Either Sex Presenting with Clinical Features of Amavata (R.A.) 2 Clinically Diagnosed and Confirmed Patient of Amavata. (Chronicity 3 Patient Willing to Sign the Consent Forms.

Exclusion criteria

Exclusion criteria: 1.Patients age below 20 and above 50 years. 2.Patients with extremely reduced joint space. 3.Patients having associated Renal function impairment RHD malignant hypertension. 4.Patients having any type of arthopathy such as neoplasm of spine Ankylosing spondylitis traumatic arthritis and pyogenic osteomyelitis etc. 5.Patients having severe crippling bone deformities

Design outcomes

Primary

MeasureTime frame
Improvement in the Subjective and Objective Parameters Before and After Treatment Timepoint: 45 days

Secondary

MeasureTime frame
Evaluation of Efficacy of Rasnadipanchdashakam Kwatha in the Management of Amavata( Rheumatoid Arthritis) Timepoint: 45 days

Countries

India

Contacts

Public ContactDr Megha Kumawat

University Post Graduate Institute of Ayurved Studies And Research Jodhpur

bkmudgal9@gmail.com9460318138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026